Abstract: This application provides an H2S scrubbing system, a column packed with an inert material, wherein an inert gas passes counter to a flow of a hydrotreated product containing H2S through said column. There is also provided a method for scrubbing H2S from a hydrotreated product, comprising providing a hydrotreated product containing H2S; and passing the hydrotreated product over a column packed with an inert material, wherein an inert gas passed counter to a flow of the hydrotreated product.

Abstract: This application provides an H2S scrubbing system, a column packed with an inert material, wherein an inert gas passes counter to a flow of a hydrotreated product containing H2S through said column. There is also provided a method for scrubbing H2S from a hydrotreated product, comprising providing a hydrotreated product containing H2S; and passing the hydrotreated product over a column packed with an inert material, wherein an inert gas passed counter to a flow of the hydrotreated product.

Abstract: An arrangement for securing a load carrier to a transporting vehicle that includes an anchor mechanism adapted for securement to a transporting vehicle and for releasable engagement with a carrier foot. The carrier foot has a latching mechanism for releasable engagement with the anchor mechanism. The latching mechanism is adapted for latching engagement to, and disengagement from the anchor mechanism by movement of the carrier foot in a direction substantially perpendicular to a longitudinal axis of the carrier foot. An example of such movement is vertical movement substantially of an up and down nature. The latching mechanism has a latching and an unlatching configuration and the latching mechanism is urged toward the latching configuration by a resilient biasing mechanism.

Abstract: An arrangement for securing a load carrier to a transporting vehicle that includes an anchor mechanism adapted for securement to a transporting vehicle and for releasable engagement with a carrier foot. The carrier foot has a latching mechanism for releasable engagement with the anchor mechanism. The latching mechanism is adapted for latching engagement to, and disengagement from the anchor mechanism by movement of the carrier foot in a direction substantially perpendicular to a longitudinal axis of the carrier foot. An example of such movement is vertical movement substantially of an up and down nature. The latching mechanism has a latching and an unlatching configuration and the latching mechanism is urged toward the latching configuration by a resilient biasing mechanism.

Abstract: An arrangement for securing a load carrier to a transporting vehicle that includes an anchor mechanism adapted for securement to a transporting vehicle and for releasable engagement with a carrier foot. The carrier foot has a latching mechanism for releasable engagement with the anchor mechanism. The latching mechanism is adapted for latching engagement to, and disengagement from the anchor mechanism by movement of the carrier foot in a direction substantially perpendicular to a longitudinal axis of the carrier foot. An example of such movement is vertical movement substantially of an up and down nature. The latching mechanism has a latching and an unlatching configuration and the latching mechanism is urged toward the latching configuration by a resilient biasing mechanism.

Abstract: The present invention provides novel rotavirus reassortants, vaccines employing the novel reassortants and methods for their preparation and administration. One such reassortant contains the gene encoding the v.p.7 neutralization antigen of a human rotavirus. Another reassortant contains the gene encoding the v.p.4 neutralization antigen of a human rotavirus. The remaining genes are provided solely from the bovine rotavirus WC3 strain, or from both the human and bovine strains.

Abstract: A microencapsulated subunit component from bovine herpes virus-1 (BHV-1) is disclosed. Vaccines, kits, and methods for using the same to vaccinate a member of a bovine species are also disclosed.

Abstract: The present invention provides novel rotavirus reassortants, vaccines employing the novel reassortants and methods for their preparation and administration. One such reassortant contains the gene encoding the v.p.7 neutralization antigen of a human rotavirus. Another reassortant contains the gene encoding the v.p.4 neutralization antigen of a human rotavirus. The remaining genes are provided solely from the bovine rotavirus WC3 strain, or from both the human and bovine strains.

Abstract: The present invention provides novel rotavirus reassortants, vaccines employing the novel reassortants and methods for their preparation and administration. One such reassortant contains the gene encoding the v.p.7 neutralization antigen of a human rotavirus. Another reassortant contains the gene encoding the v.p.4 neutralization antigen of a human rotavirus. The remaining genes are provided solely from the bovine rotavirus WC3 strain, or from both the human and bovine strains.

Abstract: The present invention provides novel rotavirus reassortants, vaccines employing the novel reassortants and methods for their preparation and administration. One such reassortant contains the gene encoding the v.p.7 neutralization antigen of a human rotavirus. Another reassortant contains the gene encoding the v.p.4 neutralization antigen of a human rotavirus. The remaining genes are provided solely from the bovine rotavirus WC3 strain, or from both the human and bovine strains.

Abstract: The present invention refers generally to a novel human cytopathic rotavirus of serotype 3 (HCR3A) and to its use as a vehicle for the expression of human rotavirus genes. The invention also relates to novel rotavirus reassortants, vaccines employing the novel rotavirus and its reassortants and methods for their preparation and administration.

Abstract: A live rotavirus vaccine against bovine and human rotaviruses comprising a strain of live bovine rotavirus which does not hemagglutinate primate red blood cells, gives at least about 20 fold higher titers when neutralized with antiserum therefor as compared to heterologous bovine or primate rotaviruses, and has a migration pattern of its RNA genome segments when determined by PAGE substantially as shown by lane WC3 in FIG. 1, the strain of bovine rotavirus having been serially passaged in primate kidney tissue culture a sufficient number of times that when administered to humans the vaccine is immunogenic without causing disease.